” or “CPN”) in 3Q18 shows total revenue of THB 9,499 mn, a decrease of 15.2% from the same period in the previous year (YoY), and net profit of THB 2,928 mn, a decrease of 51.1% YoY, mainly due to the
system. The performance of Central Pattana Public Company Limited (“The Company” or “CPN”) in 3Q19 shows total revenue of THB 9,413 mn, an increase of 2.1% and net profit stood at THB 2,816 mn, a decrease
, “Management Report”. B prudent consideration on factors in line with uncertainties stemming from the continued economic slowdown. At the end of 2019, our robust capital position was sufficient to cushion
administrative expenses to revenues stood at 16.2%. Finance Cost Finance Cost for the year of 2018 was 133.6 million, decrease from 2017 56.7 million Baht or 73.8% increase. Major of the Company’s liabilities in
subsidiary (Solaris) decreased. Bad debt and doubtful accounts decrease of Baht 4.32 million due to there are no set up this transaction for the year 2017. In the third quarter for the year 2017, The
13% to 13% and 20% yoy. It was driven by the outstanding profit for the Company and its subsidiary. In addition, the significant improvement of return on equity was from the decrease of shareholders
improve power supply capacity and escalate power to grid. Revenue from sale of industrial equipment dropped by 20.40% due to decrease in demand on products. Other revenues comprise of revenue from revenue
. Revenue from sale of industrial equipment dropped by 20.40% due to decrease in demand on products. Other revenues comprise of revenue from revenue from sale of scrap and zinc, machinery rental, together
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั